- 121.5k views
Management of Hyperbilirubinemia in the Newborn Infant
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
About the Speaker
Dr. Vishal Parmar
Consultant Critical Care , Apollo Hospitals, Mumbai
Dr. Vishal Parmar is a trained Pediatrician with extensive experience in General Pediatrics in NewBorn care & adolescent health.
Upcoming Case Discussions
Gynaecologist’s Guide to Ovarian Cancer
Join us for a special webinar on World Ovarian Cancer Day, titled "Gynaecologist’s Guide to Ovarian Cancer." This expert-led session will delve into the latest advancements in early diagnosis, risk stratification, and evidence-based management of ovarian cancer. Tailored for gynecologists and healthcare professionals, the session will also explore real-world case discussions and multidisciplinary treatment approaches. Let’s come together to raise awareness and empower clinicians in the fight against this silent but deadly disease
Massive Transfusion Protocol
Massive Transfusion Protocol (MTP) is a standardized medical procedure activated in cases of severe hemorrhage, typically involving the rapid administration of large volumes of blood products. The goal is to restore circulating volume, maintain hemostasis, and prevent the lethal triad of hypothermia, acidosis, and coagulopathy. MTP usually involves a balanced ratio of packed red blood cells, plasma, and platelets, often in a 1:1:1 ratio. Early activation and coordination among trauma teams, laboratory services, and blood banks are essential for its success.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Vishal Parmar 's Talks on Assimilate
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.